UNSPSC 51162632: Isoaminile

This classification denotes an antitussive agent with the molecular formula C16H24N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) R4823W2PQL, chemically known as valeronitrile, 4-(dimethylamino)-2-isopropyl-2-phenyl- but more generally known as isoaminile, which bears US NIH Compound Identifier 6481. European Medicines Agency schedules Isoaminile in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08310MIG.

UNSPSC 51162632 Isoaminile (Commodity) shows minimal recent state and local procurement activity directly aligned with its nominal scope. The two recent opportunities tagged to this code—one from Seminole County, Florida for naloxone and drug deactivation systems and one from the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) for generic pharmaceuticals and OTC products—represent pharmaceutical and medical supply procurement rather than isoaminile specifically. Neither solicitation names isoaminile as a line item or required ingredient, suggesting a tagging mismatch between the code classification and the actual goods being sought. State and local buyers appear to use this Commodity code inconsistently or opportunistically for broader pharmaceutical categories rather than as a targeted procurement vehicle for isoaminile itself.

Issuing bodies soliciting under this code include county health departments and state cooperative purchasing consortiums. Seminole County, Florida released an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (Solicitation Number S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a deadline of March 26, 2026. Recent activity is concentrated in Florida and the upper Midwest through cooperative purchasing mechanisms. The code does not currently reflect a viable market signal for isoaminile targeting; firms should verify actual commodity requirements before investing in response development.